Related Experiment Video
Updated: Jan 20, 2026
Intraoperative Ultrasound in Spinal Surgery
Published on: August 17, 2022
Intraoperative Autologous Blood Donation Leads to Fewer Transfusions in Cardiac Surgery
Eric Zimmermann1, Roger Zhu2, Takuya Ogami2
1Department of Surgery, New York Presbyterian Queens, Flushing, New York; Knight Cardiovascular Institute, Oregon Health Sciences University, Portland, Oregon.
Insights
Implementing intraoperative autologous blood donation (IAD) in cardiac surgery significantly reduces blood transfusions and hospital stays. This blood conservation strategy shows promise for improving patient outcomes with minimal limitations.
Area of Science:
- Cardiovascular Surgery
- Transfusion Medicine
- Patient Blood Management
Background:
- Blood conservation strategies are increasingly adopted in cardiac surgery.
- Standardized intraoperative autologous blood donation (IAD) is a key component of these protocols.
Purpose of the Study:
- To evaluate the impact of a blood conservation protocol centered on standardized intraoperative autologous blood donation (IAD).
- To analyze transfusion tendencies and patient outcomes before and after implementing a new blood conservation policy.
Main Methods:
- Retrospective chart review of 1002 cardiac surgery patients over 8 years.
- Comparison of transfusion rates and outcomes between patients before (n=352) and after (n=650) policy implementation.
- Propensity score matching to control for patient covariates and ensure comparable cohorts.
Main Results:
- Fewer patients received transfusions post-policy (61% vs 78%), with reduced units (1.81 vs 2.8).
- Shorter hospital stays (7.28 vs 8.02 days) and fewer complications (18.8% vs 29.5%) were observed.
- Propensity-matched analysis confirmed reduced postoperative transfusions and volume associated with IAD, without increased mortality.
Conclusions:
- Intraoperative autologous blood donation (IAD) is associated with reduced blood transfusions in cardiac surgery.
- IAD can be a valuable complementary aspect of blood conservation protocols with few limitations.
- Prospective studies are needed to establish a causal relationship between IAD and improved outcomes.
Background:
Blood conservation with antifibrinolytics, topical hemostatics, and strict transfusion triggers are becoming commonplace in cardiac surgery. The aim of this study was to evaluate the effect of a blood conservation protocol centering on standardized intraoperative autologous blood donation (IAD) use in cardiac surgery.
Methods:
We reviewed charts of patients who underwent cardiac surgery at our hospital over an 8-year period to analyze transfusion tendencies before and after a new blood conservation policy was implemented. Propensity score matching was used to account for population differences in preoperative and perioperative covariates.
Results:
Over an 8-year period (January 2009 to December 2017) 1002 patients were studied. Three hundred fifty-two patients before the new blood conservation policy (group 1) were compared with 650 patients after the change (group 2). Fewer group 2 patients required blood transfusions during their hospital stay (78% vs 61%, P < .001), were transfused fewer units (2.8 vs 1.81 units, P < .001), and experienced a shorter length of stay (8.02 vs 7.28 days, P = .012). Propensity score-matched cohorts revealed reductions in any complication (29.5% vs 18.8%, P = .007), fewer postoperative transfusions (70.1% vs 50.9%, P < .001), and a lower transfusion volume (1.82 vs 1.21 units, P = .002) associated with IAD without any associated change in mortality.
Conclusions:
IAD use is associated with reduced transfusions in cardiac surgery and may be considered a complementary aspect of blood conservation. Our experience suggests it may be applied with few limitations. A causal relationship between IAD and outcomes should be established with prospective studies.
More Related Videos
Related Concept Videos
01:15Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
02:45Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:22Phase-lead and Phase-lag Controllers
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:22Cardiac Output II: Effect of Stroke Volume on Cardiac Output
Preload
Preload refers to the initial elongation of the cardiac myocytes before contraction and is related to the volume of blood filling the heart at the end of diastole, or end-diastolic volume. The...